Loading chart…
PRE-MARKET
Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, ophthalmologic, antidepressant medications.
Aarti Pharmalabs Limited (AARTIPHARM) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The AARTIPHARM share price is ₹921.40 (-0.83% today), with a market capitalisation of ₹84B and a price-to-earnings (P/E) ratio of 32.6. MarketRipple tracks the AARTIPHARM investment thesis, the ripple-chain impact of market events on Aarti Pharmalabs Limited, and the Healthcare sector outlook.
Open
₹924.10
High
₹960.00
Low
₹915.60
Prev. Close
₹929.10
52W High
₹1,002.40
52W Low
₹585.00
Day range
₹915.60–₹960.00
52-week range
₹585.00–₹1,002.40
Volume
503K
P/E
32.6
ROE
8.2%
D/E
0.36
Margin
10.4%
Aarti Pharmalabs Limited (NSE: AARTIPHARM) is currently trading at ₹921.40 (-0.83%).
Aarti Pharmalabs Limited's market capitalization is ₹84B.
Aarti Pharmalabs Limited's price-to-earnings (P/E) ratio is 32.6.
Aarti Pharmalabs Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Aarti Pharmalabs Limited currently reads neutral, based on 1 analyst covering the stock. This is third-party analyst data, not a MarketRipple recommendation.